文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

注意:胃肠道症状可能是新冠病毒病的一种表现。

Beware: Gastrointestinal symptoms can be a manifestation of COVID-19.

作者信息

Schmulson M, Dávalos M F, Berumen J

机构信息

Laboratorio de Hígado, Páncreas y Motilidad (HIPAM), Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México.

Laboratorio de Hígado, Páncreas y Motilidad (HIPAM), Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México.

出版信息

Rev Gastroenterol Mex (Engl Ed). 2020 Jul-Sep;85(3):282-287. doi: 10.1016/j.rgmx.2020.04.001. Epub 2020 Apr 15.


DOI:10.1016/j.rgmx.2020.04.001
PMID:32376072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7158807/
Abstract

BACKGROUND: There is an increasing number of reports on the presentation of gastrointestinal symptoms in cases of COVID-19. AIM: To review the studies reporting gastrointestinal symptoms in COVID-19. RESULTS: Fifteen articles (2,800 patients) were identified. Gastrointestinal symptom frequency varied from 3.0% to 39.6% and included diarrhea (7.5%), náusea (4.5%), anorexia (4.4%), vomiting (1.3%), abdominal pain (0.5%), and belching/reflux (0.3%). Those symptoms can be the first manifestation of COVID-19, but whether they reflect a better or worse prognosis, is controversial. The potential relation of the angiotensin converting enzyme 2 receptor in the digestive tract as an entry route for the virus is discussed. CONCLUSION: Gastrointestinal symptoms may be common in COVID-19, in some cases appearing as the first manifestation, even before fever and respiratory symptoms. Therefore, clinicians and gastroenterologists must be aware of those atypical cases during the current pandemic, as well as of the fecal-oral route and corresponding preventive measures.

摘要

背景:关于新型冠状病毒肺炎(COVID-19)病例出现胃肠道症状的报道越来越多。 目的:综述有关COVID-19胃肠道症状的研究。 结果:共纳入15篇文章(2800例患者)。胃肠道症状发生率从3.0%到39.6%不等,包括腹泻(7.5%)、恶心(4.5%)、厌食(4.4%)、呕吐(1.3%)、腹痛(0.5%)和嗳气/反流(0.3%)。这些症状可能是COVID-19的首发表现,但它们是否预示着更好或更差的预后,仍存在争议。文中讨论了消化道中血管紧张素转换酶2受体作为病毒进入途径的潜在关系。 结论:胃肠道症状在COVID-19中可能很常见,在某些情况下甚至在发热和呼吸道症状之前就作为首发表现出现。因此,在当前疫情期间,临床医生和胃肠病学家必须意识到这些非典型病例,以及粪-口传播途径和相应的预防措施。

相似文献

[1]
Beware: Gastrointestinal symptoms can be a manifestation of COVID-19.

Rev Gastroenterol Mex (Engl Ed). 2020

[2]
COVID-19 - more than respiratory disease: a gastroenterologist's perspective.

J Physiol Pharmacol. 2020-7-2

[3]
[COVID-19 from a gastroenterological perspective].

Dtsch Med Wochenschr. 2020-7

[4]
Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians.

Einstein (Sao Paulo). 2020

[5]
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.

World J Gastroenterol. 2020-8-21

[6]
Gastrointestinal and liver manifestations of COVID-19.

Saudi J Gastroenterol. 2020

[7]
Gastrointestinal and liver manifestations in patients with COVID-19.

J Chin Med Assoc. 2020-6

[8]
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.

Lancet Gastroenterol Hepatol. 2020-5-12

[9]
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.

Aliment Pharmacol Ther. 2020-3-31

[10]
Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.

World J Gastroenterol. 2020-5-21

引用本文的文献

[1]
Using Association Rules to Obtain Sets of Prevalent Symptoms throughout the COVID-19 Pandemic: An Analysis of Similarities between Cases of COVID-19 and Unspecified SARS in São Paulo-Brazil.

Int J Environ Res Public Health. 2024-9-1

[2]
Gut microbiota composition is associated with disease severity and host immune responses in COVID-19.

Front Cell Infect Microbiol. 2023

[3]
From Emergence to Endemicity: A Comprehensive Review of COVID-19.

Cureus. 2023-10-31

[4]
PERINATAL ASPECTS OF SARS-CoV-2 INFECTION DURING PREGNANCY: A POTENTIAL CAUSE FOR CONCERN.

Acta Clin Croat. 2022-12

[5]
The causal relationship between COVID-19 and seventeen common digestive diseases: a two-sample, multivariable Mendelian randomization study.

Hum Genomics. 2023-9-26

[6]
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies.

Arch Microbiol Immunol. 2023

[7]
Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital.

Rev Peru Med Exp Salud Publica. 2023

[8]
Post-COVID-19 Syndrome Mechanisms, Prevention and Management.

Int J Prev Med. 2023-5-24

[9]
Probiotics improve symptoms of patients with COVID-19 through gut-lung axis: a systematic review and meta-analysis.

Front Nutr. 2023-5-22

[10]
Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study.

Nutrients. 2023-4-1

本文引用的文献

[1]
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.

Am J Gastroenterol. 2020-5

[2]
AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic.

Gastroenterology. 2020-8

[3]
Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection.

Gut. 2020-4-2

[4]
Covid-19 and the digestive system.

J Gastroenterol Hepatol. 2020-4-19

[5]
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.

Gut. 2020-3-24

[6]
Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18).

Rev Esp Enferm Dig. 2020-4

[7]
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China.

Clin Infect Dis. 2020-7-28

[8]
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.

Front Med. 2020-3-12

[9]
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.

Mil Med Res. 2020-3-13

[10]
A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019.

J Med Virol. 2020-3-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索